CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Samsung Bioepis Co., Ltd. vs. Genentech, Inc.

๐Ÿ“ก 5G SEP โ€ข ETSI Declared

Explore the PTAB proceeding IPR2017-01960 filed by Samsung Bioepis Co., Ltd. on 2017-08-25. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2017-01960

Filing Date

2017-08-25

Accorded Filing Date

2017-08-25

Institution Decision Date

2017-12-01

Last Modified Date

โ€”

Proceeding Type

IPR

Termination Date

2017-12-01

Trial Status

Final Written Decision

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 10356824
Respondent Patent Number 7892549
Legal Expiration Date
2023-12-11 Expired (Term Ended)
Patent Term Adjustment (PTA) +311 Days Awarded
Injunction Viability (35 U.S.C. ยง 283) Statutorily Barred
Respondent Inventor Virginia E. Paton et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Final Written Decision

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

52 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Arnold & Porter Kaye Scholer LLP
Customer Number 35489
Address 10th Floor, Three Embarcadero Center, San Francisco, CA, 94111, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
35287 Jeffrey Miller +1 650-319-4538
35910 Sean Johnston +1 650-225-3562
39209 Robert Hall +1 650-225-8203
40378 Wendy Lee +1 650-225-1994
41408 David Marsh +1 202-942-5068
46585 Brian Buckwalter +1 650-225-8018
46631 Cara Coburn +1 650-225-1000
47668 Susan Hubl +1 650-763-7326

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 2 proceedings
๐Ÿ›๏ธ
USPTO PTAB Trials 7 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (9 found):
PTAB: 7 U.S. Courts: 2
USPTO PTAB Trial 2017-10-03
IPR2018-00016

Pfizer, Inc. v. Genentech, Inc.

U.S. Continuation Sibling (7846441)
Status: Institution Denied
USPTO PTAB Trial 2017-09-06
IPR2017-02063

Pfizer, Inc. v. Genentech, Inc.

U.S. Continuation Sibling (7846441)
Status: Final Written Decision
USPTO PTAB Trial 2017-03-21
IPR2017-01121

Celltrion, Inc. et al. v. Genentech, Inc.

U.S. Continuation Sibling (7846441)
Status: Final Written Decision
USPTO PTAB Trial 2017-03-21
IPR2017-01122

Celltrion, Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-01-20
IPR2017-00739

Hospira, Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2017-01-20
IPR2017-00731

Hospira, Inc. et al. v. Genentech, Inc.

U.S. Continuation Sibling (7846441)
Status: Final Written Decision
USPTO PTAB Trial 2017-01-20
IPR2017-00737

Hospira, Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
U.S. District Court 2018-09-04
1:18-cv-01363

Genentech, Inc. v. Samsung Bioepis Co., Ltd.

Asserted Patent
Status: DED
U.S. District Court 2018-01-12
1:18-cv-00095

Genentech, Inc. v. Celltrion, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Standard Essential Patent (SEP) & FRAND Intelligence

5G SEP โ€ข ETSI Declared High-Probability SEP Action

Essential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation

FRAND Encumbered
Essential Standard 5G NR Generation: 5G
Standard Setting Org (SSO) ETSI / 3GPP Essential specification under ETSI / 3GPP governance
FRAND Commitment Committed Fair, Reasonable & Non-Discrim.
Known Patent Pools Avanci / Sisvel / Via Licensing Coverage Applicable Declarant: Samsung

Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)

Permanent Injunction Restricted

Asserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.

โœ“ Patentee bound by SSO IPR Policy (ETSI Annex 6 / IEEE Patent Policy).
โœ“ Right to demand global FRAND portfolio determination.
โœ“ Non-discrimination defense: check licensing terms offered to competing implementers.

Proceeding Documents

88
12

FINAL WRITTEN DECISION AND RELATED ORDERS Claims 1-17 Shown to Be Unpatentable 35 U.S.C. ยง 318(a); 37 C.F.R. ยง 42.73 Denying Patent Owner's Motion to Amend 35 U.S.C. ยง 316(d); 37 C.F.R. ยง 42.121 Paper

2018-10-03 FILING PARTY: BOARD
11

Order on Institution and Joinder Paper

2017-12-01 FILING PARTY: BOARD
3001

Exhibit 3001 Exhibits

2017-11-14 FILING PARTY: BOARD
10

Petitioner's Reply to Patent Owner's Opposition to Motion for Joinder Paper

2017-11-02 FILING PARTY: PETITIONER
9

Expunging Paper 8 and Resetting Case Status Paper

2017-10-30 FILING PARTY: BOARD

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc